IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Financial Information
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
- 2020
- 2021
- 2022
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Current Assets | 12,975 | 20,808 | 20,978 |
| Non-Current Assets | 36,425 | 37,448 | 24,880 |
| Total Assets | 49,400 | 58,256 | 45,857 |
| Current Liabilities | 1,044 | 1,846 | 20,539 |
| Non-Current Liabilities | 1,060 | 17,649 | 2,879 |
| Total Liabilities | 2,104 | 19,496 | 23,419 |
| Capital | 4,849 | 4,866 | 4,866 |
| Retained Earnings | -6,507 | -19,519 | -41,036 |
| Total Equity | 47,296 | 38,761 | 22,439 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Sales | 0 | 909 | 480 |
| Operating Profit | -5,287 | -13,011 | -14,911 |
| Profit before Income Tax | -4,126 | -13,071 | -22,865 |
| Net Profit | -4,126 | -13,071 | -22,865 |
| -4,126 | -13,071 | -22,865 |
